Home|Journals|Articles by Year|Audio Abstracts

Original Article

J App Pharm Sci. 2021; 11(2): 93-101

Efavirenz-loaded polymeric nanocapsules: Formulation, development, and validation of an RP-UHPLC-DAD method for drug quantification, determination of encapsulation efficiency, stability study, and dissolution profile

Amanda Martinez Lyra, Juliana Parente Menezes Ribeiro, Jessica Mendes Nadal, Sinvaldo Baglie, Traudi Klein, Andressa Novatski, Paulo Vitor Farago.

Cited by 2 Articles

This study aims at preparing efavirenz (EFV)-loaded polymeric nanocapsules and carrying out the analytical method development and validation in order to provide a suitable tool for evaluating these formulations in terms of encapsulation efficiency, stability, and dissolution profile. The nanoformulations were obtained by the interfacial deposition of preformed polymer(s). The analytical method was specific, linear (r² = 0.9990), precise, accurate, and robust from 1.0 to 50.0 μg/ml and demonstrated a drug retention time of 1.6 minutes. The mean encapsulated drug content was higher than 99.0%. All formulations showed stability problems at room temperature since the values of pH, particle size, and polydispersity index increased, while the zeta potential intensified its negative value after 60 days of storage. However, the storage in the refrigerator was able to prevent this process in most of the investigated formulations. Concerning the drug loading, all EFV-loaded nanocapsules based on poly(ε-caprolactone) and [poly(ethylene glycol) 6000] were statistically stable after 60 days of storage. The nanoencapsulation was responsible for prolonging the drug release for both EFV-loaded formulations by anomalous transport.

Key words: chromatography validation, drug release, non-nucleoside reverse transcriptase inhibitor, physicochemical stability testing, poly(ε-caprolactone)

Full-text options

Share this Article

Online Article Submission
• ejmanager.com

ejPort - eJManager.com
Refer & Earn
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.